Ban on advertising

Updated 09 March 2022

It is illegal to advertise for cannabis products covered by the pilot programme.

This ban follows from section 57 of the Act on a Medicinal Cannabis Pilot Programme and on a Scheme for Cultivation, Production, etc. of Medicinal Cannabis and applies to:

  1. cannabis end-products;
  2. cannabis intermediate products included on the published list of cannabis intermediate products, cf. section 7(4); and
  3. cannabis primary products included on the published list of cannabis primary products, cf. section 7(4).

Advertising of cannabis end-products means any form of door-to-door information, canvassing activity or inducement designed to promote the prescription, supply, sale or consumption of cannabis end-products. A cannabis end-product can be produced by a pharmacy or a hospital pharmacy from a cannabis intermediate product according to a doctor’s prescription for a specific patient.

Advertising of cannabis intermediate products and cannabis primary products admitted to the list of cannabis intermediate products and cannabis primary products means any form of door-to-door information designed to promote the supply and sale of cannabis intermediate products and cannabis primary products intended for use in cannabis end-products.